Search details
1.
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.
Blood
; 142(11): 1008-1021, 2023 09 14.
Article
in English
| MEDLINE | ID: mdl-37363859
2.
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.
Cytotherapy
; 2024 Mar 30.
Article
in English
| MEDLINE | ID: mdl-38639671
3.
Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection.
Ann Hematol
; 103(1): 285-296, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37947825
4.
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ann Hematol
; 103(3): 843-854, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38006571
5.
Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy.
Am J Hematol
; 99(2): 263-273, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38164974
6.
Essential Roles of the Transcription Factor NR4A1 in Regulatory T Cell Differentiation under the Influence of Immunosuppressants.
J Immunol
; 208(9): 2122-2130, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35387841
7.
Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
Br J Haematol
; 202(2): 356-368, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37211753
8.
Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.
Hematol Oncol
; 41(1): 147-158, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36268564
9.
Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group.
Hematol Oncol
; 41(3): 535-545, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36385399
10.
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database.
Ann Hematol
; 102(5): 1215-1227, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36918415
11.
Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group.
Ann Hematol
; 102(9): 2507-2516, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37338625
12.
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy.
Ann Hematol
; 102(10): 2879-2893, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37477669
13.
Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study.
Am J Hematol
; 98(10): 1606-1618, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37493218
14.
Clinical characteristics and risk factors of pneumococcal diseases in recipients of allogeneic hematopoietic stem cell transplants in the late phase: A retrospective registry study.
J Infect Chemother
; 29(7): 726-730, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37088144
15.
Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients.
Cytotherapy
; 24(10): 1013-1025, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35729020
16.
Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
Cytotherapy
; 24(9): 954-961, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35534419
17.
Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosis.
Hematol Oncol
; 40(5): 1076-1085, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35964301
18.
Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis.
Hematol Oncol
; 40(4): 752-762, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35299289
19.
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.
Hematol Oncol
; 40(3): 442-456, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35394658
20.
Adult patients with Ph+ ALL benefit from conditioning regimen of medium-dose VP16 plus CY/TBI.
Hematol Oncol
; 40(5): 1041-1055, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35790020